Bolt Biotherapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.51 | -$0.51 | -$0.51 |
| Q2 2024 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2024 | 3 | -$0.43 | -$0.23 | -$0.34 |
| Q4 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q2 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
Bolt Biotherapeutics, Inc. Earnings Date And Information
Bolt Biotherapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.56 earnings per share for the quarter, missing analysts' consensus estimates of $-0.54 by $0.02. The company had revenue of 1.28 M for the quarter and had revenue of 7.88 M for the year. Bolt Biotherapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.83 diluted earnings per share) and currently has a price-to-earnings ratio of -0.38. Bolt Biotherapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Bolt Biotherapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.54 | -$0.56 | -0.02 | $1.01 M | $1.28 M |
| 05/14/2024 | Q1 2024 | -$0.51 | -$0.28 | 0.23 | $5.27 M | |
| 03/21/2024 | Q4 2023 | -$0.47 | -$0.47 | 0 | $2.09 M | |
| 11/09/2023 | Q3 2023 | -$0.49 | -$0.43 | 0.06 | $1.73 M | $2.53 M |
| 08/07/2023 | Q2 2023 | -$0.53 | -$0.48 | 0.05 | $1.91 M | $1.43 M |
| 05/11/2023 | Q1 2023 | -$0.49 | -$0.41 | 0.08 | $1.83 M | |
| 03/29/2023 | Q4 2022 | -$0.63 | -$0.50 | 0.13 | $1.41 M | |
| 11/10/2022 | Q3 2022 | -$0.56 | -$0.58 | -0.02 | $990,000 | $2.11 M |
| 08/10/2022 | Q2 2022 | -$0.68 | -$0.60 | 0.08 | $500,000 | $1.39 M |
| 05/12/2022 | Q1 2022 | -$0.71 | -$0.63 | 0.08 | $813,000 | |
| 03/30/2022 | Q4 2021 | -$0.66 | -$0.73 | -0.07 | $508,000 | |
| 11/09/2021 | Q3 2021 | -$0.63 | -$0.63 | 0 | $375,000 | $752,000 |
| 08/12/2021 | Q2 2021 | -$0.38 | -$0.64 | -0.26 | $3.33 M | $0 |
| 05/13/2021 | Q1 2021 | -$0.64 | -$1.14 | -0.5 | $0 | |
| 03/31/2021 | Q4 2020 | -$1.80 | -$0.97 | 0.83 | $0 | |
| 09/29/2020 | Q3 2020 | -$0.71 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.79 | $67,000 | |||
| 03/30/2020 | Q1 2020 | -$0.62 | $164,000 | |||
| 12/30/2019 | Q4 2019 | -$0.67 | $65,000 | |||
| 09/29/2019 | Q3 2019 | -$3.54 | $121,000 |
Bolt Biotherapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Bolt Biotherapeutics, Inc.'s earnings date?
Bolt Biotherapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to Bolt Biotherapeutics, Inc.'s earnings conference call?
The conference call for Bolt Biotherapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Bolt Biotherapeutics, Inc.'s conference call transcript?
The conference call transcript for Bolt Biotherapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Bolt Biotherapeutics, Inc. generate each year?
Bolt Biotherapeutics, Inc. (:BOLT) has a recorded annual revenue of $7.88 M.
-
How much profit does Bolt Biotherapeutics, Inc. generate each year?
Bolt Biotherapeutics, Inc. (:BOLT) has a recorded net income of $7.88 M. Bolt Biotherapeutics, Inc. has generated $-1.83 earnings per share over the last four quarters.
-
What is Bolt Biotherapeutics, Inc.'s price-to-earnings ratio?
Bolt Biotherapeutics, Inc. (:BOLT) has a price-to-earnings ratio of -0.38 and price/earnings-to-growth ratio is 0.08.
